Genelux Corp (GNLX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: GNLX Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-08-30 2023-08-30 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
19,800 -12.7%
24.70
489,060 USD 		19,800 -12.7% 24.70 489,060 USD
2023-08-22 2023-08-18 S Sale

Zindrick Thomas

President and CEO

Executive Director
8,349 -36.3%
23.73
198,122 USD 		8,349 -36.3% 23.73 198,122 USD
2023-08-22 2023-08-18 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
3,265 -2.1%
23.73
77,478 USD 		3,265 -2.1% 23.73 77,478 USD
2023-08-22 2023-08-18 S Sale

Smalling Ralph

Head of Regulatory

Officer
935 -31.2%
23.73
22,188 USD 		935 -31.2% 23.73 22,188 USD
2023-08-22 2023-08-18 S Sale

Ryder Sean

General Counsel

Officer
328 -36.4%
23.73
7,783 USD 		328 -36.4% 23.73 7,783 USD
2023-08-22 2023-08-18 S Sale

Jewett Caroline

Head of Quality

Officer
515 -31.2%
23.73
12,221 USD 		515 -31.2% 23.73 12,221 USD
2023-08-22 2023-08-18 S Sale

Samuelson Doug

Chief Financial Officer

Officer
1,297 -36.0%
23.73
30,778 USD 		1,297 -36.0% 23.73 30,778 USD
2023-08-22 2023-08-18 S Sale

Cappello Joseph

VP, Pharmaceutical Development

Officer
3,265 -36.3%
23.73
77,478 USD 		3,265 -36.3% 23.73 77,478 USD
2023-01-31 2023-01-26 B Purchase

Zhang Qian

Associate VP, Research

Officer
200 +inf%
6.25
1,250 USD 		200 +inf% 6.25 1,250 USD